Kazunori Akimoto

Tokyo, 1258585, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase-1 Expression via the aPKC-NF-κB Pathway.

Auranofin Suppresses Cancer Cell Invasion by Inhibiting Heparanase-1 Expression via the aPKC-NF-κB Pathway.

Journal: International journal of molecular sciences
Published: May 19, 2026

GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method.

GGT6 as a Prognostic Biomarker and Therapeutic Target in Melanoma Using an Information-theoretical Method.

Journal: Cancer genomics & proteomics
Published: April 15, 2026

Mutual Information-based Prognostic Biomarker Discovery in Cancer Genomics: Conceptual Framework and Representative Applications of MI-POG.

Mutual Information-based Prognostic Biomarker Discovery in Cancer Genomics: Conceptual Framework and Representative Applications of MI-POG.

Journal: Cancer genomics & proteomics
Published: March 11, 2026

Identification of Inhibitors for eIF5A2-Dependent Translation Elongation by Monitoring the Translational Efficiency of Polyproline Motif in Mitochondrial Fission Regulator 1.

Identification of Inhibitors for eIF5A2-Dependent Translation Elongation by Monitoring the Translational Efficiency of Polyproline Motif in Mitochondrial Fission Regulator 1.

Journal: Biological & pharmaceutical bulletin
Published: February 23, 2026

Cell-cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer.

Cell-cell junction gene signatures as subtype-specific prognostic biomarkers in breast cancer.

Journal: PloS one
Published: January 25, 2026

Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.

Co-expression of PKCζ and ALDH1A3 Is Associated With Poor Chemotherapeutic Responses in Basal-like Breast Cancer.

Journal: Cancer genomics & proteomics
Published: November 23, 2025

PKCζ, CTNNBIP1 and ALDH1A3 Expression in Luminal B Breast Cancer Indicates Decreased Hormone Therapy Effectiveness.

PKCζ, CTNNBIP1 and ALDH1A3 Expression in Luminal B Breast Cancer Indicates Decreased Hormone Therapy Effectiveness.

Journal: Cancer diagnosis & prognosis
Published: September 12, 2025

High p62 and ALDH1A3 Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer.

High p62 and ALDH1A3 Reduce the Effectiveness of Endocrine Therapy in Luminal B Breast Cancer.

Journal: Cancer diagnosis & prognosis
Published: August 23, 2025

High Expression of PKCζ and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

High Expression of PKCζ and ALDH1A3 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

Journal: Anticancer research
Published: June 28, 2025

High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

High Expression of PKCζ And CTNNBIP1 Is Associated With Poor Prognosis in Luminal B Breast Cancer.

Journal: Cancer genomics & proteomics
Published: March 31, 2025

Polyamines stimulate the protein synthesis of the translation initiation factor eIF5A2, participating in mRNA decoding, distinct from eIF5A1.

Polyamines stimulate the protein synthesis of the translation initiation factor eIF5A2, participating in mRNA decoding, distinct from eIF5A1.

Journal: The Journal of biological chemistry
Published: December 24, 2024

Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations.

Asymmetric cell division of ALDH1-positive cancer stem cells generates glycolytic metabolically diverse cell populations.

Journal: Scientific reports
Published: August 28, 2024
Showing 1-12 of 56

Last Updated: 09/26/2026